Literature DB >> 17917527

Guidelines for prevention of cardiovascular disease in women: a summary of recommendations.

Lori Mosca1.   

Abstract

Cardiovascular disease (CVD) is a major cause of mortality in women. The first evidence-based guidelines for the prevention of CVD in women were developed in 2004 and updated this year. The 2007 guidelines place more emphasis on women's overall lifetime coronary heart disease risk, as opposed to short-term absolute risk, than did the 2004 recommendations. Depending on the criteria met, women are classified as being at high risk, at risk, or at optimal risk. The authors provide an overview of the recommendations in the 3 different categories: lifestyle interventions, major risk factor interventions, and preventive drug interventions.

Entities:  

Mesh:

Year:  2007        PMID: 17917527     DOI: 10.1111/j.1520-037x.2007.07255.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  10 in total

Review 1.  Cardiovascular disease and primary ovarian insufficiency.

Authors:  Melissa Wellons
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

2.  Validity of two brief physical activity questionnaires with accelerometers among African-American women.

Authors:  Rodney P Joseph; Colleen Keller; Marc A Adams; Barbara E Ainsworth
Journal:  Prim Health Care Res Dev       Date:  2015-07-16       Impact factor: 1.458

3.  Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry.

Authors:  Eric D Peterson; David Dai; Elizabeth R DeLong; J Matthew Brennan; Mandeep Singh; Sunil V Rao; Richard E Shaw; Matthew T Roe; Kalon K L Ho; Lloyd W Klein; Ronald J Krone; William S Weintraub; Ralph G Brindis; John S Rumsfeld; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

Review 4.  What do we know about metabolic syndrome in adolescents with PCOS?

Authors:  Derya Akdağ Cırık; Berna Dilbaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-03-01

5.  Adherence of hospital-based cardiologists to lipid guidelines in patients at high risk for cardiovascular events (2L registry).

Authors:  Anselm K Gitt; Claus Jünger; Christina Jannowitz; Barbara Karmann; Jochen Senges; Kurt Bestehorn
Journal:  Clin Res Cardiol       Date:  2010-10-21       Impact factor: 5.460

6.  Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines.

Authors:  Ankur Pandya; Milton C Weinstein; Joshua A Salomon; David Cutler; Thomas A Gaziano
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-01-14

7.  Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score.

Authors:  Yamnia I Cortés; Nancy Reame; Cosmina Zeana; Haomiao Jia; David C Ferris; Elizabeth Shane; Michael T Yin
Journal:  J Womens Health (Larchmt)       Date:  2016-09-09       Impact factor: 2.681

8.  Associations of visceral fat area and physical activity levels with the risk of metabolic syndrome in postmenopausal women.

Authors:  Izabela Zając-Gawlak; Barbara Kłapcińska; Aleksandra Kroemeke; Dariusz Pośpiech; Jana Pelclová; Miroslava Přidalová
Journal:  Biogerontology       Date:  2017-03-18       Impact factor: 4.277

9.  Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital.

Authors:  Chukwunonso Isaiah Enechukwu; Anaelechi Jude Onuegbu; Madu Japheth Olisekodiaka; George Uchenna Eleje; Joseph Ifeanyichukwu Ikechebelu; Joseph Odirichukwu Ugboaja; Ubuo Kalu Amah; John Ekenedirichukwu Okwara; Anthony Osita Igwegbe
Journal:  Obstet Gynecol Sci       Date:  2019-08-06

Review 10.  Complications and challenges associated with polycystic ovary syndrome: current perspectives.

Authors:  Stefano Palomba; Susanna Santagni; Angela Falbo; Giovanni Battista La Sala
Journal:  Int J Womens Health       Date:  2015-07-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.